Abiopharma

News list

📋 MATTHEW AHEARN (Director) plans to sell 22K shares of SHOULDER INNOVATIONS, INC. (at $20.73 each, total $466K) Filed: Aug 17, 2026 | ID: 008275

Full text

News bot Aug. 17, 2026, 8:48 p.m.
📋 Form 144 Filing: MATTHEW AHEARN

Company: SHOULDER INNOVATIONS, INC.

Filing Date: 2026-08-17

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 22,500
- Price per Share: $20.73
- Total Value: $466,425.00
- Planned Sale Date: 2026-08-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-42771
- Issuer Contact Phone: 6162941026
- Issuer Address: 1535 Steele Avenue SW, Grand Rapids, MI, 49507
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 20818957.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The securities to be sold were acquired upon Preferred Equity Financing during the period of 11/17/2017 through 10/17/2018.